JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on October 8, 2003; DOI: 10.1124/jpet.103.053421


0022-3565/03/3073-1098-1103$20.00
JPET 307:1098-1103, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.053421v1
307/3/1098    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gonlachanvit, S.
Right arrow Articles by Owyang, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gonlachanvit, S.
Right arrow Articles by Owyang, C.

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

Ginger Reduces Hyperglycemia-Evoked Gastric Dysrhythmias in Healthy Humans: Possible Role of Endogenous Prostaglandins

Sutep Gonlachanvit, Yen Hsueh Chen, William L. Hasler, Wei Ming Sun, and Chung Owyang

Division of Gastroenterology, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan

Acute hyperglycemia evokes gastric slow wave dysrhythmias via endogenous prostaglandin generation. Ginger exhibits slow wave antiarrhythmic effects in other models, but its actions on hyperglycemia-evoked gastric dysrhythmias are unexplored. We hypothesized that ginger prevents disruption of slow wave rhythm by acute hyperglycemia via inhibition of prostaglandin production but not its actions. Twenty-two healthy humans underwent fasting electrogastrography during hyperglycemic clamping to 250 to 290 mg/dl after double-blind placebo or ginger root (1 g). Responses were compared with the prostaglandin E1 analog misoprostol (400 µg). Dominant frequencies (DF) and the percentage of recording times in the bradygastric [0.5–2 cycles/min (cpm)], normal (2–4 cpm), and tachygastric (4–9 cpm) frequency ranges were analyzed. After placebo, hyperglycemia reduced normal 2 to 4 cpm activity from 94.4 ± 2.6 to 66.0 ± 10.4%, increased the DF from 2.96 ± 0.04 to 4.09 ± 0.45 cpm, and increased tachygastria from 2.0 ± 1.4 to 29.3 ± 10.7% (P < 0.05). Hyperglycemia effects on normal activity (77.3 ± 8.3%), DF (3.46 ± 0.37 cpm), and tachygastria (15.6 ± 8.6%) were significantly reduced by ginger (P < 0.05). Misoprostol evoked decreases in normal activity from 95.4 ± 2.0 to 81.7 ± 3.0% and increases in tachygastria from 3.1 ± 1.6 to 11.2 ± 2.4% (P < 0.05). However, ginger did not correct these abnormalities versus placebo (P = N.S.). In conclusion, acute hyperglycemia evokes gastric slow wave dysrhythmias that are prevented by ginger root. Conversely, the compound has no effect on dysrhythmias elicited by a prostaglandin E1 analog, indicating that ginger likely acts to blunt production of prostaglandins rather than inhibiting their action. These findings suggest novel mechanisms for the traditional Chinese herbal remedy ginger.


Received April 24, 2003; accepted August 21, 2003.

Address correspondence to: Dr. Chung Owyang, Division of Gastroenterology, 3912 Taubman Center, Box 0362, Ann Arbor, MI 48109. E-mail: cowyang{at}umich.edu




This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
L. A. Bradshaw, J. A. Sims, and W. O. Richards
Noninvasive assessment of the effects of glucagon on the gastric slow wave
Am J Physiol Gastrointest Liver Physiol, November 1, 2007; 293(5): G1029 - G1038.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
F. Borrelli, R. Capasso, G. Aviello, M. H. Pittler, and A. A. Izzo
Effectiveness and Safety of Ginger in the Treatment of Pregnancy-Induced Nausea and Vomiting
Obstet. Gynecol., April 1, 2005; 105(4): 849 - 856.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.